6-32828938-C-T
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001290043.2(TAP2):c.2029G>A(p.Glu677Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000841 in 1,546,504 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/18 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001290043.2 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TAP2 | NM_001290043.2 | c.2029G>A | p.Glu677Lys | missense_variant | 12/12 | ENST00000374897.4 | NP_001276972.1 | |
TAP2 | NM_018833.3 | c.1932+462G>A | intron_variant | NP_061313.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TAP2 | ENST00000374897.4 | c.2029G>A | p.Glu677Lys | missense_variant | 12/12 | 1 | NM_001290043.2 | ENSP00000364032 | A2 |
Frequencies
GnomAD3 genomes AF: 0.0000592 AC: 9AN: 152104Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.00000667 AC: 1AN: 149928Hom.: 0 AF XY: 0.00 AC XY: 0AN XY: 80710
GnomAD4 exome AF: 0.00000287 AC: 4AN: 1394400Hom.: 0 Cov.: 40 AF XY: 0.00000145 AC XY: 1AN XY: 687564
GnomAD4 genome AF: 0.0000592 AC: 9AN: 152104Hom.: 0 Cov.: 31 AF XY: 0.0000673 AC XY: 5AN XY: 74328
ClinVar
Submissions by phenotype
MHC class I deficiency Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 15, 2021 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function output the following: SIFT: "Tolerated"; PolyPhen-2: "Not Available"; Align-GVGD: "Class C0". The lysine amino acid residue is found in multiple mammalian species, suggesting that this missense change does not adversely affect protein function. These predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with TAP2-related conditions. This variant is not present in population databases (ExAC no frequency). This sequence change replaces glutamic acid with lysine at codon 677 of the TAP2 protein (p.Glu677Lys). The glutamic acid residue is weakly conserved and there is a small physicochemical difference between glutamic acid and lysine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at